ClinicalTrials.Veeva

Menu

Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation (VNI_SLA)

A

AGIR à Dom

Status

Terminated

Conditions

ALS
Charcot Disease

Treatments

Other: Teleconsultation assisted by a physiotherapist or nurse

Study type

Interventional

Funder types

Other

Identifiers

NCT05621213
2022-A01667-36

Details and patient eligibility

About

Satisfaction of patients with amyotrophic lateral sclerosis under non-invasive ventilation regarding home assisted teleconsultation

Full description

Amyotrophic Lateral Sclerosis (ALS) is a progressive and rapidly progressing neurodegenerative disease. Depending on the degree of muscle damage, patients may suffer from reduced mobility, difficulty swallowing, speech difficulties and finally respiratory weakness. Death occurs within an average of 2-3 years and is usually due to respiratory failure. Currently there is no cure for ALS, so palliative care and symptomatic treatments are essential for the management of these patients.

The gold standard treatment for respiratory impairment is non-invasive ventilation (NIV). The aim of this mask ventilation is to improve gas exchange by compensating for the weakness of the respiratory muscles.

The progressive nature of ALS requires regular assessment of the patient's clinical condition and evaluation of NIV parameters. Regular medical appointments are therefore essential to ensure optimal ventilation and close surveillance of the patient. A day hospitalization or a consultation is organized every 3 or 4 months. These visits can cause significant fatigue, not only because of the difficulty patients have to move around but also because of the time spent waiting in hospital.

ALS is characterised by its severity and it requires our society to think about and implement new ways of managing the disease. Thus, e-health innovations could be an interesting potential in the remote follow-up of these patients, to reduce the burden of hospital consultations.

The hypothesis is that the patient will be more satisfied with a home assisted teleconsultation follow-up, while keeping the same quality of non-invasive nocturnal ventilatory assistance.

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with a diagnosis of ALS coming for a follow-up consultation with their pneumologist
  • Daily NIV compliance of more than 4 hours in the month prior to inclusion
  • Living at home
  • Patient with a natural caregiver
  • Patient equipped with computer equipment adapted for teleconsultation (tablet, computer, telephone... with an internet connection)
  • Patient able to read and understand the procedure, and able to express consent for the study protocol
  • Patient, or his or her caregiver, able to sign the consent to participate by himself or herself

Exclusion criteria

  • Patient not available or wishing to change region within 3 months of inclusion
  • Patient currently participating or having participated in the month prior to inclusion in another clinical interventional research study that may have an impact on the study, this impact is left to the discretion of the investigator
  • Persons referred to in articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to all protected persons)
  • Pregnant women (for women of childbearing age and in the absence of reliable contraception, the β-HCG (human chorionic gonadotropin) assay will be performed), parturient women, breastfeeding women,
  • persons deprived of their liberty by judicial or administrative decision,
  • persons under legal protection

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

38 participants in 2 patient groups

Intervention
Experimental group
Description:
Patients who will be followed up by teleconsultation assisted by a physiotherapist or a nurse at home.
Treatment:
Other: Teleconsultation assisted by a physiotherapist or nurse
Control group
No Intervention group
Description:
Patients not wishing to be followed up by teleconsultation but agreeing to participate in the study and the collection of questionnaires. They will follow up as usual in person (no teleconsultation).

Trial contacts and locations

2

Loading...

Central trial contact

Céline Barra; Jean-Christian Borel, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems